HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $66 Price Target
Mirum Pharmaceuticals +1.67% Pre
Mirum Pharmaceuticals MIRM | 39.54 38.60 | +1.67% -2.38% Pre |
HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:
MIRM) with a Buy and maintains $66 price target.